CONCENTRIX CORP (CNXC) Fundamental Analysis & Valuation

NASDAQ:CNXC • US20602D1019

Current stock price

31.67 USD
-0.05 (-0.16%)
At close:
31.67 USD
0 (0%)
After Hours:

This CNXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CNXC Profitability Analysis

1.1 Basic Checks

  • CNXC had positive earnings in the past year.
  • In the past year CNXC had a positive cash flow from operations.
  • CNXC had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years CNXC had a positive operating cash flow.
CNXC Yearly Net Income VS EBIT VS OCF VS FCFCNXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • The Return On Assets of CNXC (-11.92%) is worse than 72.41% of its industry peers.
  • CNXC's Return On Equity of -46.75% is on the low side compared to the rest of the industry. CNXC is outperformed by 68.97% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.97%, CNXC is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CNXC is below the industry average of 10.73%.
  • The last Return On Invested Capital (6.97%) for CNXC is above the 3 year average (6.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -11.92%
ROE -46.75%
ROIC 6.97%
ROA(3y)-2.48%
ROA(5y)1.38%
ROE(3y)-11.11%
ROE(5y)-0.44%
ROIC(3y)6.4%
ROIC(5y)8.19%
CNXC Yearly ROA, ROE, ROICCNXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • With a decent Operating Margin value of 7.24%, CNXC is doing good in the industry, outperforming 64.37% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CNXC has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 34.96%, CNXC is in line with its industry, outperforming 52.87% of the companies in the same industry.
  • CNXC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.24%
PM (TTM) N/A
GM 34.96%
OM growth 3Y-12.1%
OM growth 5Y0.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.69%
GM growth 5Y-0.14%
CNXC Yearly Profit, Operating, Gross MarginsCNXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

2

2. CNXC Health Analysis

2.1 Basic Checks

  • CNXC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CNXC has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CNXC has been increased compared to 5 years ago.
  • CNXC has a worse debt/assets ratio than last year.
CNXC Yearly Shares OutstandingCNXC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CNXC Yearly Total Debt VS Total AssetsCNXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • CNXC has an Altman-Z score of 1.35. This is a bad value and indicates that CNXC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CNXC (1.35) is worse than 63.22% of its industry peers.
  • CNXC has a debt to FCF ratio of 8.10. This is a slightly negative value and a sign of low solvency as CNXC would need 8.10 years to pay back of all of its debts.
  • CNXC has a Debt to FCF ratio (8.10) which is in line with its industry peers.
  • CNXC has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CNXC (1.67) is worse than 71.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 8.1
Altman-Z 1.35
ROIC/WACC0.82
WACC8.45%
CNXC Yearly LT Debt VS Equity VS FCFCNXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.40 indicates that CNXC should not have too much problems paying its short term obligations.
  • CNXC has a worse Current ratio (1.40) than 62.07% of its industry peers.
  • CNXC has a Quick Ratio of 1.40. This is a normal value and indicates that CNXC is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CNXC (1.40) is worse than 60.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4
CNXC Yearly Current Assets VS Current LiabilitesCNXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

4

3. CNXC Growth Analysis

3.1 Past

  • The earnings per share for CNXC have decreased by -1.49% in the last year.
  • The Earnings Per Share has been decreasing by -1.50% on average over the past years.
  • Looking at the last year, CNXC shows a small growth in Revenue. The Revenue has grown by 2.15% in the last year.
  • CNXC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.80% yearly.
EPS 1Y (TTM)-1.49%
EPS 3Y-1.5%
EPS 5YN/A
EPS Q2Q%-9.51%
Revenue 1Y (TTM)2.15%
Revenue growth 3Y15.82%
Revenue growth 5Y15.8%
Sales Q2Q%4.29%

3.2 Future

  • Based on estimates for the next years, CNXC will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.68% on average per year.
  • Based on estimates for the next years, CNXC will show a small growth in Revenue. The Revenue will grow by 2.90% on average per year.
EPS Next Y7.86%
EPS Next 2Y9.23%
EPS Next 3Y11.68%
EPS Next 5YN/A
Revenue Next Year3.3%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNXC Yearly Revenue VS EstimatesCNXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
CNXC Yearly EPS VS EstimatesCNXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

8

4. CNXC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 2.82, which indicates a rather cheap valuation of CNXC.
  • CNXC's Price/Earnings ratio is rather cheap when compared to the industry. CNXC is cheaper than 95.40% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CNXC to the average of the S&P500 Index (25.70), we can say CNXC is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 2.62, the valuation of CNXC can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CNXC is valued cheaply inside the industry as 98.85% of the companies are valued more expensively.
  • CNXC is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.82
Fwd PE 2.62
CNXC Price Earnings VS Forward Price EarningsCNXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNXC indicates a rather cheap valuation: CNXC is cheaper than 95.40% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNXC indicates a rather cheap valuation: CNXC is cheaper than 97.70% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.4
EV/EBITDA 4.56
CNXC Per share dataCNXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y9.23%
EPS Next 3Y11.68%

5

5. CNXC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.01%, CNXC is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.93, CNXC pays a better dividend. On top of this CNXC pays more dividend than 96.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CNXC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.01%

5.2 History

  • CNXC has been paying a dividend for over 5 years, so it has already some track record.
  • CNXC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
CNXC Yearly Dividends per shareCNXC Yearly Dividends per shareYearly Dividends per share 2016 2017 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • The earnings of CNXC are negative and hence is the payout ratio. CNXC will probably not be able to sustain this dividend level.
DP-6.99%
EPS Next 2Y9.23%
EPS Next 3Y11.68%
CNXC Yearly Income VS Free CF VS DividendCNXC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

CNXC Fundamentals: All Metrics, Ratios and Statistics

CONCENTRIX CORP

NASDAQ:CNXC (3/13/2026, 8:18:16 PM)

After market: 31.67 0 (0%)

31.67

-0.05 (-0.16%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)01-13
Earnings (Next)03-24
Inst Owners100.56%
Inst Owner Change-3.25%
Ins Owners0.55%
Ins Owner Change0.79%
Market Cap1.94B
Revenue(TTM)9.83B
Net Income(TTM)-1.28B
Analysts81.82
Price Target57.89 (82.79%)
Short Float %20.05%
Short Ratio8.02
Dividend
Industry RankSector Rank
Dividend Yield 4.01%
Yearly Dividend1.42
Dividend Growth(5Y)N/A
DP-6.99%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-30
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.79%
Min EPS beat(2)-4.97%
Max EPS beat(2)-0.61%
EPS beat(4)1
Avg EPS beat(4)-0.83%
Min EPS beat(4)-4.97%
Max EPS beat(4)5.92%
EPS beat(8)3
Avg EPS beat(8)-0.36%
EPS beat(12)4
Avg EPS beat(12)-0.82%
EPS beat(16)6
Avg EPS beat(16)-1.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-1.03%
Revenue beat(4)0
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-1.65%
Max Revenue beat(4)-0.48%
Revenue beat(8)0
Avg Revenue beat(8)-1.19%
Revenue beat(12)0
Avg Revenue beat(12)-1.55%
Revenue beat(16)0
Avg Revenue beat(16)-1.86%
PT rev (1m)0%
PT rev (3m)-12.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 2.82
Fwd PE 2.62
P/S 0.2
P/FCF 3.4
P/OCF 2.41
P/B 0.71
P/tB N/A
EV/EBITDA 4.56
EPS(TTM)11.22
EY35.43%
EPS(NY)12.1
Fwd EY38.21%
FCF(TTM)9.33
FCFY29.45%
OCF(TTM)13.15
OCFY41.52%
SpS160.11
BVpS44.72
TBVpS-47.05
PEG (NY)0.36
PEG (5Y)N/A
Graham Number106.25
Profitability
Industry RankSector Rank
ROA -11.92%
ROE -46.75%
ROCE 8.3%
ROIC 6.97%
ROICexc 7.25%
ROICexgc 22.91%
OM 7.24%
PM (TTM) N/A
GM 34.96%
FCFM 5.83%
ROA(3y)-2.48%
ROA(5y)1.38%
ROE(3y)-11.11%
ROE(5y)-0.44%
ROIC(3y)6.4%
ROIC(5y)8.19%
ROICexc(3y)6.6%
ROICexc(5y)8.47%
ROICexgc(3y)25.29%
ROICexgc(5y)29.29%
ROCE(3y)7.62%
ROCE(5y)9.75%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y2.28%
ROICexc growth 3Y-11.61%
ROICexc growth 5Y0.58%
OM growth 3Y-12.1%
OM growth 5Y0.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.69%
GM growth 5Y-0.14%
F-Score4
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 8.1
Debt/EBITDA 3.33
Cap/Depr 35.51%
Cap/Sales 2.39%
Interest Coverage 2.37
Cash Conversion 58.84%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z 1.35
F-Score4
WACC8.45%
ROIC/WACC0.82
Cap/Depr(3y)38.61%
Cap/Depr(5y)42.97%
Cap/Sales(3y)2.47%
Cap/Sales(5y)2.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.49%
EPS 3Y-1.5%
EPS 5YN/A
EPS Q2Q%-9.51%
EPS Next Y7.86%
EPS Next 2Y9.23%
EPS Next 3Y11.68%
EPS Next 5YN/A
Revenue 1Y (TTM)2.15%
Revenue growth 3Y15.82%
Revenue growth 5Y15.8%
Sales Q2Q%4.29%
Revenue Next Year3.3%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.6%
EBIT growth 3Y1.8%
EBIT growth 5Y16.12%
EBIT Next Year30.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.53%
FCF growth 3Y7.51%
FCF growth 5Y11.23%
OCF growth 1Y20.9%
OCF growth 3Y10.34%
OCF growth 5Y9.71%

CONCENTRIX CORP / CNXC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CONCENTRIX CORP (CNXC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CNXC.


Can you provide the valuation status for CONCENTRIX CORP?

ChartMill assigns a valuation rating of 8 / 10 to CONCENTRIX CORP (CNXC). This can be considered as Undervalued.


How profitable is CONCENTRIX CORP (CNXC) stock?

CONCENTRIX CORP (CNXC) has a profitability rating of 4 / 10.


What are the PE and PB ratios of CONCENTRIX CORP (CNXC) stock?

The Price/Earnings (PE) ratio for CONCENTRIX CORP (CNXC) is 2.82 and the Price/Book (PB) ratio is 0.71.


Can you provide the expected EPS growth for CNXC stock?

The Earnings per Share (EPS) of CONCENTRIX CORP (CNXC) is expected to grow by 7.86% in the next year.